BIOTRONIK Neuro Launches AI-Powered Embrace One Platform
LAKE OSWEGO, Ore., July 20, 2026 BIOTRONIK Neuro has unveiled Embrace OneĀ® Proactive Intelligence, a proprietary artificial intelligence (AI)...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Device Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
LAKE OSWEGO, Ore., July 20, 2026 BIOTRONIK Neuro has unveiled Embrace OneĀ® Proactive Intelligence, a proprietary artificial intelligence (AI)...
SYDNEY, Australia and AUCKLAND, New Zealand, June 21, 2026 MurjĀ®, a leading provider of cardiac device management software, has...
